Published by Josh White on 18th July 2018
(Sharecast News) - Novel immunotherapies developer Scancell Holdings has exercised its option to a worldwide commercial licence for the use of Ichor Medical Systems' proprietary 'TriGrid 2.0' electroporation delivery system with SCIB1 - Scancell's 'ImmunoBody' vaccine for the treatment of melanoma - it announced on Wednesday.